carbapenems has been researched along with chloramphenicol in 9 studies
Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (chloramphenicol) | Trials (chloramphenicol) | Recent Studies (post-2010) (chloramphenicol) |
---|---|---|---|---|---|
7,355 | 147 | 5,277 | 20,113 | 388 | 1,464 |
Protein | Taxonomy | carbapenems (IC50) | chloramphenicol (IC50) |
---|---|---|---|
30S ribosomal protein S6 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S7 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L15 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L10 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L11 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L7/L12 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L19 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L1 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L20 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L27 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L28 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L29 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L31 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L31 type B | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L32 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L33 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L34 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L35 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L36 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S10 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S11 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S12 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S13 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S16 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S18 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S19 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S20 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S2 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S3 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S4 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S5 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S8 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S9 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L13 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L14 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L16 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L23 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S15 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L17 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L21 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L30 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L6 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S14 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S17 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S1 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L18 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L2 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L3 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L24 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L4 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L22 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L5 | Escherichia coli K-12 | 0.43 | |
30S ribosomal protein S21 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L25 | Escherichia coli K-12 | 0.43 | |
50S ribosomal protein L36 2 | Escherichia coli K-12 | 0.43 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Powell, M; Seetulsingh, P; Williams, JD | 1 |
Hoogkamp-Korstanje, JA; Schouten, MA; Voss, A | 1 |
Curty, LK; Epp, SF; Köhler, T; Pechère, JC | 1 |
Al Dahouk, S; Dierich, MP; Hofer, E; Neubauer, H; Splettstoesser, WD; Tomaso, H; Treu, TM | 1 |
Chen, M; Guo, P; Sun, H; Wang, H; Xu, Y; Yang, Q; Zhu, Y | 1 |
Brook, I | 2 |
Correia, A; Henriques, IS; Tacão, M | 1 |
Grafl, B; Hess, C; Hess, M; Maegdefrau, M | 1 |
2 review(s) available for carbapenems and chloramphenicol
Article | Year |
---|---|
Treatment of anaerobic infection.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Chloramphenicol; Clindamycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Metronidazole; Microbial Sensitivity Tests; Minocycline; Negative-Pressure Wound Therapy; Penicillins; Tigecycline | 2007 |
Spectrum and treatment of anaerobic infections.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactamase Inhibitors; Carbapenems; Cefoxitin; Chloramphenicol; Clindamycin; Drug Resistance, Bacterial; Humans; Metronidazole; Minocycline; Penicillins; Tigecycline | 2016 |
7 other study(ies) available for carbapenems and chloramphenicol
Article | Year |
---|---|
In-vitro susceptibility of Haemophilus influenzae to meropenem compared with imipenem, five other beta-lactams, chloramphenicol and ciprofloxacin.
Topics: Ampicillin; Anti-Bacterial Agents; Carbapenems; Chloramphenicol; Ciprofloxacin; Culture Media; Haemophilus influenzae; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Thienamycins | 1989 |
Antimicrobial susceptibility patterns of enterococci causing infections in Europe. The European VRE Study Group.
Topics: Anti-Bacterial Agents; Carbapenems; Cefpirome; Cephalosporins; Chloramphenicol; Enterococcus faecalis; Enterococcus faecium; Europe; Fluoroquinolones; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillins | 1999 |
Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa.
Topics: 4-Quinolones; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Biological Transport, Active; Carbapenems; Chloramphenicol; Cloning, Molecular; Drug Resistance, Multiple; Gene Expression Regulation, Bacterial; Genes, Bacterial; Molecular Sequence Data; Mutation; Operon; Phenotype; Porins; Pseudomonas aeruginosa; RNA Processing, Post-Transcriptional; Sequence Analysis, DNA; Transcription, Genetic; Trimethoprim | 1999 |
Antimicrobial susceptibilities of Austrian Francisella tularensis holarctica biovar II strains.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Austria; Carbapenems; Cephalosporins; Chloramphenicol; Francisella tularensis; Hares; Humans; Microbial Sensitivity Tests; Quinolones; Rifampin; Tetracycline; Tularemia | 2005 |
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
Topics: Acinetobacter; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Blotting, Southern; Carbapenems; China; Chloramphenicol; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Rifampin; Sequence Analysis, DNA | 2007 |
Low Prevalence of Carbapenem-Resistant Bacteria in River Water: Resistance Is Mostly Related to Intrinsic Mechanisms.
Topics: Aeromonas; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Chloramphenicol; Chromobacterium; Enterobacteriaceae; Environmental Monitoring; Gene Expression; Microbial Sensitivity Tests; Plasmids; Portugal; Pseudomonas; Quinolones; Rivers; Shewanella; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination; Water Microbiology | 2015 |
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Chloramphenicol; Colistin; Drug Resistance, Multiple; Enrofloxacin; Flavobacteriaceae Infections; Nalidixic Acid; Ornithobacterium; Oxacillin; Poultry Diseases; Tetracyclines; Turkeys; Tylosin | 2022 |